Top Story

Adjuvant chemotherapy may improve lung cancer outcomes in older patients

February 25, 2015

Adjuvant chemotherapy may improve survival for older patients with stage I non–small cell lung cancer, according to an analysis of the SEER–Medicare database.

However, the regimen also is associated with serious adverse events, according to an analysis of the SEER-Medicare database.

Naiyer A. Rizvi, MD Institution Notes

Medical Center appoints director of thoracic oncology immunotherapeutics

February 23, 2015
Naiyer A. Rizvi, MD, has been named director of thoracic oncology and immunotherapeutics in medical oncology at NewYork-Presbyterian/Columbia University Medical…
Lori C. Sakoda, PhD, MPH In the Journals

Metformin may reduce lung cancer risk for nonsmokers with diabetes

February 19, 2015
Use of metformin appeared to offer a protective effect against lung cancer among nonsmokers with diabetes, according to results of a retrospective study.“Our study…
Navi B. Babak, MD In the Journals

Incident cancer linked to increased short-term stroke risk

February 17, 2015
Patients with a new cancer diagnosis have an elevated risk for subsequent stroke, according to study results.Babak Navi, MD, assistant professor of neurology and…
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
In the Journals

Adjuvant chemotherapy may improve lung cancer outcomes in older patients

February 25, 2015
Adjuvant chemotherapy may improve survival for older patients with stage I non–small cell lung cancer, according to an analysis of the…
Naiyer A. Rizvi, MD Institution Notes

Medical Center appoints director of thoracic oncology immunotherapeutics

February 23, 2015
Naiyer A. Rizvi, MD, has been named director of thoracic oncology and immunotherapeutics in medical oncology at NewYork-Presbyterian/Columbia…
Lori C. Sakoda, PhD, MPH In the Journals

Metformin may reduce lung cancer risk for nonsmokers with diabetes

February 19, 2015
Use of metformin appeared to offer a protective effect against lung cancer among nonsmokers with diabetes, according to results of a retrospective…
Navi B. Babak, MD In the Journals

Incident cancer linked to increased short-term stroke risk

February 17, 2015
Patients with a new cancer diagnosis have an elevated risk for subsequent stroke, according to study results.Babak Navi, MD, assistant professor of…
Julie Brahmer, MD Institution Notes

Kimmel Cancer Center appoints director of thoracic oncology

February 16, 2015
Julie Brahmer, MD, a medical oncologist with extensive experience in the use of immunotherapies to treat lung cancer, has been named director of the…
FDA NewsDrug Pipeline

FDA grants orphan drug designation to VS-5584 for mesothelioma

February 12, 2015
The FDA granted orphan drug designation to VS-5584 for the treatment of mesothelioma, according to a press release from the drug’s…
William C. Black, MD In the Journals

Lung-RADS may reduce false-positives in lung cancer screening

February 9, 2015
The use of Lung Imaging Reporting and Data System criteria during interpretation of low-dose CT scan results may yield lower false-positive results…
Daniel B. Costa, MD, PhD In the Journals

Crizotinib associated with systemic, intracranial disease control in ALK-rearranged NSCLC

February 9, 2015
Patients with ALK-rearranged non–small cell lung cancer who had brain metastases demonstrated systemic and intracranial disease control with…
In the Journals

CMS finalizes decision to cover lung cancer screening

February 6, 2015
CMS released a final national coverage determination that covers low-dose CT lung cancer screening for Medicare beneficiaries who meet risk criteria…
FDA News

FDA grants breakthrough therapy designation to MPDL3280A for PDL1–positive NSCLC

February 2, 2015
The FDA granted breakthrough therapy designation to MPDL3280A for the treatment of patients with PD-L1–positive non–small cell lung…
More Headlines »
morganatic-roan